American International Group Inc. Boosts Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

American International Group Inc. grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.0% during the 4th quarter, HoldingsChannel reports. The fund owned 13,229 shares of the medical device company’s stock after acquiring an additional 137 shares during the quarter. American International Group Inc.’s holdings in Cooper Companies were worth $5,006,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. EP Wealth Advisors LLC purchased a new position in shares of Cooper Companies in the fourth quarter worth $406,000. Syon Capital LLC purchased a new position in shares of Cooper Companies in the fourth quarter worth $218,000. V Square Quantitative Management LLC increased its stake in shares of Cooper Companies by 24.6% in the fourth quarter. V Square Quantitative Management LLC now owns 1,094 shares of the medical device company’s stock worth $414,000 after buying an additional 216 shares during the period. Parkman Healthcare Partners LLC increased its stake in shares of Cooper Companies by 15.1% in the fourth quarter. Parkman Healthcare Partners LLC now owns 75,183 shares of the medical device company’s stock worth $28,452,000 after buying an additional 9,862 shares during the period. Finally, Point72 Asset Management L.P. increased its stake in shares of Cooper Companies by 65.3% in the fourth quarter. Point72 Asset Management L.P. now owns 240,317 shares of the medical device company’s stock worth $90,946,000 after buying an additional 94,906 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

COO opened at $91.51 on Friday. The stock has a 50-day moving average price of $92.95 and a 200-day moving average price of $94.68. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The firm has a market cap of $18.22 billion, a PE ratio of 53.83, a P/E/G ratio of 2.27 and a beta of 1.02. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $104.07.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. The firm had revenue of $942.60 million during the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. Cooper Companies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.77 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.57 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on COO. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. TheStreet cut shares of Cooper Companies from a “b-” rating to a “c” rating in a report on Thursday, February 29th. Robert W. Baird lifted their price target on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a report on Friday, May 31st. Piper Sandler lifted their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Friday, March 1st. Finally, Citigroup lifted their price target on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.42.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.